Varian Medical Systems (VAR) Misses Q1 EPS by 3c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Equities close higher as softer jobs data quiets rate-hike expectations
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Varian Reports Results for First Quarter of Fiscal Year 2020
January 29, 2020 4:09 PM ESTPALO ALTO, Calif., Jan. 29, 2020 /PRNewswire/ --
First Quarter 2020 Summary
Oncology Systems gross orders grew 8% in dollars or 9% in constant currency in the quarter and over the trailing twelve months Total company revenues grew 12% in dollars, or 13% in constant currency, to $829 million; organic revenues grew 8%(1) GAAP operating earnings declined 1% at 13.3% of revenues; non-GAAP operating earnings grew 13% at 16.2% of revenues GAAP net earnings per diluted share of $0.96; non-GAAP net earnings per diluted share of $1.16 No change to fiscal year 2020 guidance(1)Â Excludes the year-over-year impact of foreign... More
